Replies to post #79100 on PharmaCyte Biotech Inc (PMCB)

[Kano58]

Could be because it will be cheaper in Canada, you get 28% more on the Dollar. Also, the Canadian government has recently approved the production of cannabis for medical purposes. Some of the Directors of the Board also come from Canada or at least got their doctor's degree there.

[Kano58]

After reading about Practical Clinical on their website, I can see why Pharmacyte choose them. I probably would choose this company also, if I was in the shoes of Pharmacyte. A down-to-earth Canadian low profile enterprise, with the best interest of the client in mind, to help them in their clinical trials. The testimonials on their website from some US pharmas (yes, US ones) have commented on Practical Clinical's professionalism and it speaks volumes.

[PINKribbon]

I believe in one way or another von Hoff is tied into that “suggestion”.

As far as any conflict with TD2...it’s certainly possible.

I mean the timing of that negotiated contract and TD2’s “said” notification of their infrastructure problem certainly could be viewed as a questionable coincidence at the very least.

What if the new contract was struck because of some certain foreseeable changes and/or developments. Changes that TD2 may not of been happy with. Then perhaps a conflict(s) did arise.

BUT, I myself, tend to think what KW said....is so.

Reason being, if there was a conflict, I just don’t believe von Hoff would still be participating. If KW says TD2 doesn’t have an adequate infrastructure, then I believe it. And soon, a new CRO will be chosen.

And who knows?...it could very well be a Canadian CRO. :) :) :)

I can say one thing is certain, if there was indeed “any” conflict...we’ll never know.

[esusun]

Interesting

http://practicalclinical.com/practical-experience/

all 3 previously with Abraxis / Celgene , and Amgen

hoping for some great news prior to the next Q